{"AllianceGenome": "4511", "HGNC": "4511", "MIM": "604107", "_id": "9290", "_version": 1, "accession": {"genomic": ["AC012507.9", "AC092534.4", "AF096786.1", "CH471063.1", "CP068276.2", "NC_000002.12", "NC_060926.1", "NG_050956.1"], "protein": ["AAD22410.1", "AAH32694.1", "ACI96303.1", "BAF84912.1", "CAG46575.1", "EAW70939.1", "EAW70940.1", "NP_005674.2", "Q9Y2T6.2", "XP_005247009.1", "XP_011510477.1", "XP_011510478.1", "XP_054200542.1", "XP_054200543.1", "XP_054200544.1"], "rna": ["AK292223.1", "BC032694.1", "CR541776.1", "FJ348259.1", "NM_005683.4", "XM_005246952.5", "XM_011512175.4", "XM_011512176.3", "XM_054344567.1", "XM_054344568.1", "XM_054344569.1"], "translation": [{"protein": "ACI96303.1", "rna": "FJ348259.1"}, {"protein": "CAG46575.1", "rna": "CR541776.1"}, {"protein": "XP_054200543.1", "rna": "XM_054344568.1"}, {"protein": "BAF84912.1", "rna": "AK292223.1"}, {"protein": "XP_011510477.1", "rna": "XM_011512175.4"}, {"protein": "AAH32694.1", "rna": "BC032694.1"}, {"protein": "NP_005674.2", "rna": "NM_005683.4"}, {"protein": "XP_054200544.1", "rna": "XM_054344569.1"}, {"protein": "XP_054200542.1", "rna": "XM_054344567.1"}, {"protein": "XP_011510478.1", "rna": "XM_011512176.3"}, {"protein": "XP_005247009.1", "rna": "XM_005246952.5"}]}, "alias": "LPIR1", "ensembl": {"gene": "ENSG00000135898", "protein": ["ENSP00000375893", "ENSP00000375894", "ENSP00000410267", "ENSP00000412768", "ENSP00000482381", "ENSP00000498258"], "transcript": ["ENST00000392039", "ENST00000392040", "ENST00000438398", "ENST00000444078", "ENST00000622008", "ENST00000650999"], "translation": [{"protein": "ENSP00000410267", "rna": "ENST00000444078"}, {"protein": "ENSP00000375893", "rna": "ENST00000392039"}, {"protein": "ENSP00000412768", "rna": "ENST00000438398"}, {"protein": "ENSP00000498258", "rna": "ENST00000650999"}, {"protein": "ENSP00000482381", "rna": "ENST00000622008"}, {"protein": "ENSP00000375894", "rna": "ENST00000392040"}], "type_of_gene": "protein_coding"}, "entrezgene": "9290", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 4.79453849, "exp_mis": 114.9586657, "exp_syn": 51.8172, "lof_z": -0.0929494346088731, "mis_z": 0.545543570268064, "mu_lof": 3.8617486132e-07, "mu_mis": 1.01092165461e-05, "mu_syn": 4.53637834384e-06, "n_lof": 5.0, "n_mis": 103.0, "n_syn": 59.0, "p_li": 0.000388569399865933, "p_null": 0.603051093425196, "p_rec": 0.396560337174937, "syn_z": -0.618594787700765}, "bp": 960, "cds_end": 231775677, "cds_start": 231774717, "n_exons": 1, "nonpsych": {"exp_lof": 4.3188845, "exp_mis": 104.0280534, "exp_syn": 46.8789362, "lof_z": 0.150695251161047, "mis_z": 0.545364603113008, "mu_lof": 3.8617486132e-07, "mu_mis": 1.01092165461e-05, "mu_syn": 4.53637834384e-06, "n_lof": 4.0, "n_mis": 93.0, "n_syn": 55.0, "p_li": 0.00254897794658842, "p_null": 0.475842237473434, "p_rec": 0.521608784579977, "syn_z": -0.746770914332434}, "nontcga": {"exp_lof": 4.40896425, "exp_mis": 105.759969, "exp_syn": 47.66982025, "lof_z": 0.192131386582962, "mis_z": 0.472821927743158, "mu_lof": 3.8617486132e-07, "mu_mis": 1.01092165461e-05, "mu_syn": 4.53637834384e-06, "n_lof": 4.0, "n_mis": 96.0, "n_syn": 54.0, "p_li": 0.00252581733306448, "p_null": 0.447960507721099, "p_rec": 0.549513674945837, "syn_z": -0.580519221065496}, "transcript": "ENST00000392040.1"}, "exons": [{"cdsend": 230910962, "cdsstart": 230910002, "chr": "2", "position": [[230907327, 230911096], [230925167, 230925242]], "strand": -1, "transcript": "NM_005683", "txend": 230925242, "txstart": 230907327}], "exons_hg19": [{"cdsend": 231775677, "cdsstart": 231774717, "chr": "2", "position": [[231772042, 231775811], [231789882, 231789957]], "strand": -1, "transcript": "NM_005683", "txend": 231789957, "txstart": 231772042}], "generif": [{"pubmed": 17765871, "text": "These results strongly suggest that GPR55 is a specific and functional receptor for lysophosphatidylinositol."}, {"pubmed": 17876302, "text": "The GPR55 is a novel cannabinoid receptor, it binds to and is activated by the cannabinoid ligand CP55940 and couples to Galpha13 and can mediate activation of rhoA, cdc42 and rac1."}, {"pubmed": 18263732, "text": "establish GPR55 as a cannabinoid receptor with signaling distinct from CB(1) and CB(2)."}, {"pubmed": 18445684, "text": "in endothelial cells, two receptors for anandamide were found, which were characterized as cannabinoid 1 receptor & and G-protein-coupled receptor 55; integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55"}, {"pubmed": 18757503, "text": "Treatment with lysophosphatidylinositol induces marked GPR55 internalization and stimulates a sustained, oscillatory calcium release pathway, which is dependent on Galpha13 and requires RhoA activation."}, {"pubmed": 19723626, "text": "GPR55 is an atypical cannabinoid responder."}, {"pubmed": 19805329, "text": "Data reveal a role of GPR55 in bone physiology by regulating osteoclast number and function."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20051382, "text": "results suggest that GPR55 and its endogenous ligand LPI play essential roles in the homoeostatic responses to stress signals in several mammalian tissues and cells including certain types of immune cells"}, {"pubmed": 20506567, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20506567, "text": "this study demonistrated that low-functioning Val195 allele of GPR55 appears to be a risk factor for anorexia nervosa."}, {"pubmed": 20549374, "text": "HIV-infected human cells injected into immunodeficient mice to observe expression levels of CB1R, CB2R and GPR55."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20818416, "text": "GPR55 expression in human tumors from different origins correlates with tumor aggressiveness. Moreover, GPR55 promotes cancer cell proliferation through the overactivation of the extracellular signal-regulated kinase cascade."}, {"pubmed": 20838378, "text": "GPR55 is expressed in several prostate and ovarian cancer cell lines and has a critical role in regulating proliferation and anchorage-independent growth. GPR55 mediates the effects of lysophosphatidylinositol in prostate and ovarian cancer cells."}, {"pubmed": 21367464, "text": "GPR55 is expressed in human tumours and drives proliferation and its expression correlates with tumour aggressiveness"}, {"pubmed": 21467997, "text": "GPR55 limits the tissue-injuring inflammatory responses mediated by CB(2)R, while it synergizes with CB(2)R in recruiting neutrophils to sites of inflammation."}, {"pubmed": 21534610, "text": "The chemical diversity provided by three lead compounds combined with the identification of key GPR55 receptor interaction sites should provide a basis for the design of more efficacious second-generation GPR55 ligands that retain GPR55 selectivity."}, {"pubmed": 21537344, "text": "New blood brothers: the GPR55 and CB2 partnership"}, {"pubmed": 21718301, "text": "GASP-1 is a key regulator of the trafficking and, by extension, functional expression of GPR55"}, {"pubmed": 22179809, "text": "alpha-lysophosphatidylinositol(LPI)/GPR55 system is positively associated with obesity in humans."}, {"pubmed": 22285325, "text": "Studies suggest the lysophosphatidylinositol (LPI)/orphan G protein-coupled receptor GPR55 axis plays an important role in different physiological and pathological contexts."}, {"pubmed": 22751111, "text": "GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas."}, {"pubmed": 22820167, "text": "This review presents a summary of what is known about the G-protein coupled receptors GPR35 and GPR55 and their potential characterization as lysophospholipid or cannabinoid receptors, respectively--{REVIEW}"}, {"pubmed": 23151004, "text": "This article reviews current data about GPR55 pharmacology and signalling, highlighting its involvement in several pathophysiological conditions. [review]"}, {"pubmed": 23161546, "text": "CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55."}, {"pubmed": 23603203, "text": "Data (including data from tissue bank samples) suggest that GPR55 is strongly expressed on myenteric neurons of the colon."}, {"pubmed": 23639801, "text": "Data suggest that GPR55 is functionally expressed in vascular endothelium/platelets and is involved in regulation of calcium signaling; as suspected, lysophosphatidylinositol is a ligand/agonist for GPR55."}, {"pubmed": 24274581, "text": "GPR55 antagonists occupies a horizontal binding pocket extending into the extracellular loop region, a central ligand portion that fits vertically in the receptor binding pocket."}, {"pubmed": 24652077, "text": "GPR55 receptors were expressed in urothelial cell lines and interact with CB1 receptors."}, {"pubmed": 24942731, "text": "CB2R and GPR55 form heteromers in cancer cells, these structures possess unique signaling properties, and modulation of these heteromers can modify the antitumoral activity of cannabinoids in vivo"}, {"pubmed": 24972076, "text": "This review summarizes our current knowledge of expression and function of GPR55 in tissues involved in metabolic regulation and the signaling cascades through which GPR55 is reported to act."}, {"pubmed": 25048571, "text": "Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling"}, {"pubmed": 25233417, "text": "Data suggest GPR55 (G-protein coupled receptor 55), ABCC1 (ATP-binding cassette sub-family C), and MPR1/ABCB1 (multidrug resistance protein 1) participate/cooperate in autocrine communication/tumorigenesis involving lysophosphatidylinositol. [REVIEW]"}, {"pubmed": 25344934, "text": "proinflammatory role in innate immunity"}, {"pubmed": 25545857, "text": "expression of CB1 and GPR55 in proximal tubules is altered in response to elevated levels of glucose and albumin"}, {"pubmed": 25869640, "text": "GPR55 is expressed in placenta,located solely at the placental endothelium; L-alpha-lysophosphatidylinositol (LPI), the endogenous ligand of GPR55, increases migratory activity of venous but not arterial placental endothelial cells suggesting a role of LPI-GPR55 axis in placental venous endothelium function"}, {"pubmed": 25889562, "text": "GPR55 was a direct target gene of miR-675-5p."}, {"pubmed": 25970609, "text": "GPR55 could play deleterious role in ox-LDL-induced foam cells and could be a novel pharmacological target to manage atherosclerosis and other related cardiovascular diseases."}, {"pubmed": 25989290, "text": "Inhibiting the pro-angiogenic L-alpha-lysophosphatidylinositol /GPR55 pathway appears a promising target against angiogenesis in ovarian carcinoma"}, {"pubmed": 26436760, "text": "GPR55 is involved in the migratory behaviour of colon carcinoma cells."}, {"pubmed": 26588872, "text": "The signalling pathways activated by lysophosphatidylinositol through its receptor GPR55 play a pivotal role in different cancer. [review]"}, {"pubmed": 27423937, "text": "Inhibition of GPR55 activity produces antitumor effects via attenuation of the MEK/ERK and PI3K-AKT pathways leading to a reduction in the expression and function of MDR proteins."}, {"pubmed": 27561953, "text": "GPR55 was highly expressed by beta-cells of both humans and mice. It was also present in a small proportion of mouse islet alpha-cells and in the majority of human islet alpha-cells, but it was absent or at very low levels in delta-cells of both species.  GPR55 was preferentially expressed in the endocrine pancreas, with only faint immunoreactivity in the exocrine pancreas in mice and humans."}, {"pubmed": 28005346, "text": "Crucial amino acid residues involved in agonist signaling at the GPR55 receptor have been identified."}, {"pubmed": 28272905, "text": "We observed a significantly higher expression of GPR55 mRNA in Crohn's disease (CD) patients compared to ulcerative colitis (UC) and controls. CD patients manifested higher GPR55 mRNA expression in inflamed compared with non-inflamed colonic tissues. In contrast, the analysis of GPR55 mRNA expression in UC patients revealed no statistically significant differences between inflamed and non-inflamed colonic tissue."}, {"pubmed": 28875496, "text": "our data suggest that GPR55 and CB1 play differential roles in colon carcinogenesis where the former seems to act as oncogene and the latter as tumor suppressor."}, {"pubmed": 29188802, "text": "GPR55 is involved in the migratory behavior of human breast cancer cells."}, {"pubmed": 29435814, "text": "The GPR55 gene expressions were significantly lower in the Dorsolateral Prefrontal Cortex of suicide cases."}, {"pubmed": 29888782, "text": "Our findings support the hypothesis that neural stem cells (NSC) express functional GPR55 and that targeting GPR55 with selective agonists increases NSC proliferation and early neurogenesis both in vitro and in vivo. A better understanding of the role GPR55 plays during neurogenesis may provide new prospects for therapeutic treatments utilizing this receptor as a target."}, {"pubmed": 30830860, "text": "Study found GPR55 expression downregulated in salivary gland mucoepidermoid carcinomas and GPR55 reinstatement by antitumor irradiation, suggesting that GPR55 controls renegade proliferation. GPR55 antagonism increases cell proliferation and function determination in quasiphysiological systems. GPR55 signaling in epithelial cells ensures both the life-long renewal of ductal cells and the continuous availability of saliva"}, {"pubmed": 30890410, "text": "hypertension can be mitigated via CB1 agonism and impaired adrenoceptor responsiveness prevented by functional GPR55."}, {"pubmed": 31149342, "text": "Results provide evidence that l-alpha-Lysophosphatidylinositol (LPI) aggravates myocardial ischemia/reperfusion injury via a GPR55/ROCK-dependent pathway."}, {"pubmed": 31200545, "text": "The authors conclude that hepatitis C virus induces lncR 8 expression, while lncR 8 indirectly favors hepatitis C virus replication by stimulating expression of its neighboring gene GPR55, which in turn downregulates expression of ISGs. The latter fact is also consistent with an anti-inflammatory role of GPR55."}, {"pubmed": 31925452, "text": "The cannabinoid ligands SR141716A and AM251 enhance human and mouse islet function via GPR55-independent signalling."}, {"pubmed": 32121640, "text": "Ginseng Gintonin Contains Ligands for GPR40 and GPR55."}, {"pubmed": 32329085, "text": "The L-alpha-Lysophosphatidylinositol/G Protein-Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis."}, {"pubmed": 33902596, "text": "Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning."}, {"pubmed": 33952459, "text": "Expression of Lysophosphatidylinositol Signaling-relevant Molecules in Colorectal Cancer."}, {"pubmed": 33959968, "text": "BRET analysis reveals interaction between the lysophosphatidic acid receptor LPA2 and the lysophosphatidylinositol receptor GPR55 in live cells."}, {"pubmed": 34237432, "text": "Lysophosphatidylglucoside is a GPR55 -mediated chemotactic molecule for human monocytes and macrophages."}, {"pubmed": 34271437, "text": "Interactions between lysophosphatidylinositol receptor GPR55 and sphingosine-1-phosphate receptor S1P5 in live cells."}, {"pubmed": 34324032, "text": "Expression of the putative cannabinoid receptor GPR55 is increased in endometrial carcinoma."}, {"pubmed": 34948125, "text": "Gene Expression Data Mining Reveals the Involvement of GPR55 and Its Endogenous Ligands in Immune Response, Cancer, and Differentiation."}, {"pubmed": 35562947, "text": "Prognostic Significance of GPR55 mRNA Expression in Colon Cancer."}, {"pubmed": 37544935, "text": "Lysophosphatidylglucoside/GPR55 signaling promotes foam cell formation in human M2c macrophages."}, {"pubmed": 37688769, "text": "A comprehensive survival and prognosis analysis of GPR55 expression in hepatocellular carcinoma."}, {"pubmed": 37866808, "text": "Modulation of PI3K/Akt/GSK3beta signaling cascade through G protein-coupled receptor 55 (GPR55) activation: Prenatal lysophosphatidylinositol attenuates valproic acid-induced synaptic abnormalities and mitochondrial dysfunction."}, {"pubmed": 37998380, "text": "Elucidation of GPR55-Associated Signaling behind THC and LPI Reducing Effects on Ki67-Immunoreactive Nuclei in Patient-Derived Glioblastoma Cells."}], "genomic_pos": {"chr": "2", "end": 230961066, "ensemblgene": "ENSG00000135898", "start": 230907318, "strand": -1}, "genomic_pos_hg19": {"chr": "2", "end": 231825781, "start": 231772033, "strand": -1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0007186", "pubmed": 9931487, "qualifier": "involved_in", "term": "G protein-coupled receptor signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007200", "qualifier": "involved_in", "term": "phospholipase C-activating G protein-coupled receptor signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0035025", "qualifier": "involved_in", "term": "positive regulation of Rho protein signal transduction"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035025", "pubmed": [18757503, 19805329], "qualifier": "involved_in", "term": "positive regulation of Rho protein signal transduction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0038171", "qualifier": "involved_in", "term": "cannabinoid signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045453", "pubmed": 19805329, "qualifier": "involved_in", "term": "bone resorption"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045671", "pubmed": 19805329, "qualifier": "involved_in", "term": "negative regulation of osteoclast differentiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0070374", "pubmed": 19805329, "qualifier": "involved_in", "term": "positive regulation of ERK1 and ERK2 cascade"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": 18757503, "qualifier": "located_in", "term": "plasma membrane"}], "MF": [{"category": "MF", "evidence": "TAS", "id": "GO:0004930", "pubmed": 9931487, "qualifier": "enables", "term": "G protein-coupled receptor activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0004949", "qualifier": "enables", "term": "cannabinoid receptor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004949", "pubmed": 19723626, "qualifier": "enables", "term": "cannabinoid receptor activity"}]}, "homologene": {"genes": [[7955, 793909], [8364, 100490418], [9544, 711323], [9598, 470673], [9606, 9290], [9615, 486157], [9913, 539107], [10090, 227326], [10116, 501177]], "id": 36184}, "interpro": [{"desc": "G protein-coupled receptor, rhodopsin-like", "id": "IPR000276", "short_desc": "GPCR_Rhodpsn"}, {"desc": "GPCR, rhodopsin-like, 7TM", "id": "IPR017452", "short_desc": "GPCR_Rhodpsn_7TM"}], "ipi": ["IPI00328871", "IPI00917455"], "map_location": "2q37.1", "name": "G protein-coupled receptor 55", "other_names": "G-protein coupled receptor 55", "pantherdb": {"HGNC": "4511", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "2685064", "ortholog_type": "LDO", "panther_family": "PTHR24232", "taxid": 10090, "uniprot_kb": "Q3UJF0"}, {"RGD": "1559828", "ortholog_type": "LDO", "panther_family": "PTHR24232", "taxid": 10116, "uniprot_kb": "F1MAK4"}, {"Ensembl": "ENSGALG00000005544", "ortholog_type": "LDO", "panther_family": "PTHR24232", "taxid": 9031, "uniprot_kb": "F1NRF0"}, {"ZFIN": "ZDB-GENE-080204-17", "ortholog_type": "O", "panther_family": "PTHR24232", "taxid": 7955, "uniprot_kb": "A0A0G2KLE8"}, {"Ensembl": "ENSDARG00000113303", "ortholog_type": "O", "panther_family": "PTHR24232", "taxid": 7955, "uniprot_kb": "A0A2R8RJ90"}, {"WormBase": "WBGene00016570", "ortholog_type": "O", "panther_family": "PTHR24232", "taxid": 6239, "uniprot_kb": "H2KZ99"}], "uniprot_kb": "Q9Y2T6"}, "pathway": {"reactome": [{"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-372790", "name": "Signaling by GPCR"}, {"id": "R-HSA-373076", "name": "Class A/1 (Rhodopsin-like receptors)"}, {"id": "R-HSA-388396", "name": "GPCR downstream signalling"}, {"id": "R-HSA-418594", "name": "G alpha (i) signalling events"}, {"id": "R-HSA-500792", "name": "GPCR ligand binding"}], "wikipathways": {"id": "WP117", "name": "GPCRs, Other"}}, "pfam": "PF00001", "pharmgkb": "PA28900", "pharos": {"target_id": 2952, "tdl": "Tclin"}, "prosite": "PS50262", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF259923", "relationship": "is"}, {"id": "GNF259924", "relationship": "is"}, {"id": "GNF259925", "relationship": "is"}, {"id": "GNF259926", "relationship": "is"}], "GNF_hs-GPCR_IDT-siRNA": [{"id": "GNF280632", "relationship": "is"}, {"id": "GNF280633", "relationship": "is"}, {"id": "GNF280634", "relationship": "is"}, {"id": "GNF280635", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF156868", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF082842", "relationship": "is"}, {"id": "GNF082843", "relationship": "is"}, {"id": "GNF082844", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054111", "relationship": "is"}, {"id": "GNF058891", "relationship": "is"}, {"id": "GNF074182", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF069019", "relationship": "is"}, {"id": "GNF069020", "relationship": "is"}], "GNF_hs_LentiORF-HA-MYC": {"id": "GNF282393", "relationship": "is"}, "GNF_hs_LentiORF-Jred": {"id": "GNF283320", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF006051", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF093159", "relationship": "is"}, {"id": "GNF132857", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000002.12", "NC_060926.1", "NG_050956.1"], "protein": ["NP_005674.2", "XP_005247009.1", "XP_011510477.1", "XP_011510478.1", "XP_054200542.1", "XP_054200543.1", "XP_054200544.1"], "rna": ["NM_005683.4", "XM_005246952.5", "XM_011512175.4", "XM_011512176.3", "XM_054344567.1", "XM_054344568.1", "XM_054344569.1"], "translation": [{"protein": "XP_054200543.1", "rna": "XM_054344568.1"}, {"protein": "XP_011510477.1", "rna": "XM_011512175.4"}, {"protein": "NP_005674.2", "rna": "NM_005683.4"}, {"protein": "XP_054200544.1", "rna": "XM_054344569.1"}, {"protein": "XP_054200542.1", "rna": "XM_054344567.1"}, {"protein": "XP_011510478.1", "rna": "XM_011512176.3"}, {"protein": "XP_005247009.1", "rna": "XM_005246952.5"}]}, "reporter": {"HG-U133_Plus_2": ["231745_at", "237559_at"], "HTA-2_0": "TC02002856.hg.1", "HuEx-1_0": "2603320", "HuGene-1_1": "8059674", "HuGene-2_1": "16909464"}, "summary": "This gene belongs to the G-protein-coupled receptor superfamily. The encoded integral membrane protein is a likely cannabinoid receptor. It may be involved in several physiological and pathological processes by activating a variety of signal transduction pathways. [provided by RefSeq, Aug 2013].", "symbol": "GPR55", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1415245"}, "unigene": "Hs.114545", "uniprot": {"Swiss-Prot": "Q9Y2T6", "TrEMBL": ["C9J1P7", "A8K858"]}, "wikipedia": {"url_stub": "GPR55"}}